Exploratory analysis of the potential for advanced diagnostic testing to reduce healthcare expenditures of patients hospitalized with meningitis or encephalitis
Open Access
- 15 January 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (1) , e0226895
Abstract
To estimate healthcare expenditures that could be impacted by advanced diagnostic testing for patients hospitalized with meningitis or encephalitis Patients hospitalized with meningitis (N = 23,933) or encephalitis (N = 7,858) in the U.S. were identified in the 2010–2014 Truven Health MarketScan Commercial Claims and Encounters Database using ICD-9-CM diagnostic codes. The database included an average of 40.8 million commercially insured enrollees under age 65 per year. Clinical, demographic and healthcare utilization criteria were used to identify patient subgroups early in their episode who were at risk to have high inpatient expenditures. Healthcare expenditures of patients within each subgroup were bifurcated: those expenditures that remained five days after the patient could be classified into the subgroup versus those that had occurred previously. The hospitalization episode rate per 100,000 enrollee-years for meningitis was 13.0 (95% CI: 12.9–13.2) and for encephalitis was 4.3 (95% CI: 4.2–4.4), with mean inpatient expenditures of $36,891 (SD = $92,636) and $60,181 (SD = $130,276), respectively. If advanced diagnostic testing had been administered on the day that a patient could be classified into a subgroup, then a test with a five-day turnaround time could impact the following mean inpatient expenditures that remained by subgroup for patients with meningitis or encephalitis, respectively: had a neurosurgical procedure ($83,337 and $56,020), had an ICU stay ($34,221 and $46,051), had HIV-1 infection or a previous organ transplant ($37,702 and $62,222), were age 2 days ($18,325 and $30,244). Inpatient expenditures for patients hospitalized with meningitis or encephalitis were substantial and varied widely. Patient subgroups who had high healthcare expenditures could be identified early in their stay, raising the potential for advanced diagnostic testing to lower these expenditures.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (K08NS096117)
This publication has 30 references indexed in Scilit:
- Diagnosis of Neuroinvasive Astrovirus Infection in an Immunocompromised Adult With Encephalitis by Unbiased Next-Generation SequencingClinical Infectious Diseases, 2015
- California’s Hospital Fair Pricing Act Reduced The Prices Actually Paid By Uninsured PatientsHealth Affairs, 2015
- Encephalitis Hospitalization Rates and Inpatient Mortality in the United States, 2000-2010PLOS ONE, 2014
- Actionable Diagnosis of Neuroleptospirosis by Next-Generation SequencingNew England Journal of Medicine, 2014
- Burden of encephalitis-associated hospitalizations in the United States, 1998–2010Neurology, 2014
- Predictors of outcome in acute encephalitisNeurology, 2013
- Trends in the Management of Viral Meningitis at United States Children’s HospitalsPediatrics, 2013
- U.S. Emergency Department Visits for Meningitis, 1993–2008Academic Emergency Medicine, 2012
- Burden of Encephalitis‐Associated Hospitalizations in the United States, 1988–1997Clinical Infectious Diseases, 2002
- Clinical predictors of outcome in encephalitis.Archives of Disease in Childhood, 1987